Horst-Dieter Hummel

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Horst-Dieter Hummel

Feb 5, 2025, 05:42 | Science

Management of adverse events in patients receiving Tarlatamab for previously treated SCLC by Jacob Sands et al.

On 28 January a paper by Jacob Sands, Medical Oncologist at Dana-Farber Cancer Institute, and…

Feb 4, 2025, 16:48 | Science

Durable responses in SCLC with Tarlatamab by Jacob Sands et al. - ACS Journal Cancer

ACS Journal Cancer shared a post on X about a recent paper by Jacob Sands…

Sep 4, 2024, 06:47 | Insight

Jarushka Naidoo: Intracranial activity of Tarlatamab in 2L SCLC in Ph I DeLLphi-300 Trial

Jarushka Naidoo shared on X: "Intracranial activity of Tarlatamab in 2L SCLC in Ph I…

Aug 31, 2024, 20:07 | Insight

5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…

All: 4 Posts: 1 - 100

'

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

'

Who From Oncology is Featured in TIME100 Health 2025?

'

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot

'

The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023